We are live on ! Find out more
ETON icon

Eton Pharmaceutcials

39 hedge funds and large institutions have $54.9M invested in Eton Pharmaceutcials in 2020 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 18 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more capital invested

Capital invested by funds: $36.6M → $54.9M (+$18.3M)

1.04% more ownership

Funds ownership: 32.52%33.57% (+1%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

5% less funds holding

Funds holding: 4139 (-2)

29% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 7

44% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 18

Holders
39
Holders Change
-2
Holders Change %
-4.88%
% of All Funds
0.79%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
5
Increased
10
Reduced
18
Closed
7
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
OM
1
Opaleye Management
Massachusetts
$28.8M
BlackRock
2
BlackRock
New York
$7.85M +$1.99M +292,175 +42%
AIC
3
AWM Investment Company
New York
$4.91M -$1.24M -180,936 -23%
Vanguard Group
4
Vanguard Group
Pennsylvania
$4.45M +$1.4M +204,872 +57%
State Street
5
State Street
Massachusetts
$1.41M +$184K +26,980 +18%
Northern Trust
6
Northern Trust
Illinois
$1.31M +$753K +110,238 +199%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$1.17M +$285K +41,815 +39%
PPA
8
Parametric Portfolio Associates
Washington
$677K +$464K +67,982 +383%
Russell Investments Group
9
Russell Investments Group
United Kingdom
$645K +$558K +81,705 New
MML Investors Services
10
MML Investors Services
Massachusetts
$602K +$521K +76,250 New
Royal Bank of Canada
11
Royal Bank of Canada
Ontario, Canada
$469K -$6.75K -988 -2%
N
12
Nuveen
North Carolina
$301K
Charles Schwab
13
Charles Schwab
California
$279K -$90.2K -13,209 -27%
Bank of New York Mellon
14
Bank of New York Mellon
New York
$268K +$2.15K +315 +0.9%
DC
15
Diametric Capital
Massachusetts
$246K -$1.36M -198,670 -86%
Creative Planning
16
Creative Planning
Kansas
$227K +$196K +28,735 New
California State Teachers Retirement System (CalSTRS)
17
California State Teachers Retirement System (CalSTRS)
California
$176K
PCM
18
Prelude Capital Management
New York
$164K -$924K -135,364 -87%
Wells Fargo
19
Wells Fargo
California
$162K -$58.7K -8,592 -30%
TRCT
20
Tower Research Capital (TRC)
New York
$110K -$13.3K -1,950 -12%
MAM
21
Martingale Asset Management
Massachusetts
$91K +$77.9K +11,404 New
Citadel Advisors
22
Citadel Advisors
Florida
$90K +$77.6K +11,372 New
Bank of America
23
Bank of America
North Carolina
$89K -$158K -23,161 -67%
JP Morgan Chase
24
JP Morgan Chase
New York
$78K -$8.1K -1,186 -11%
New York State Common Retirement Fund
25
New York State Common Retirement Fund
New York
$71K -$51.2K -7,500 -45%

ETON Hedge Fund Activity: Q3 2020 in Review

39 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Eton Pharmaceutcials (ETON) for Q3 2020, worth a combined $54.9M — up 50% from $36.6M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of ETON and 5 opened new positions — a net loss of 2 holders — while 18 trimmed existing stakes and 10 added.

The largest buyer was BlackRock, adding an estimated $1.99M. The largest seller was Diametric Capital, cutting an estimated $1.36M.

  • 39 institutional investors held Eton Pharmaceutcials (ETON) as of Q3 2020, down from 41 in Q2 2020.
  • Funds reported $54.9M of Eton Pharmaceutcials stock for Q3 2020, up 50% quarter-over-quarter.
  • 5 funds opened new Eton Pharmaceutcials positions in Q3 2020 and 7 closed out, a net change of -2 holders.
  • The largest Eton Pharmaceutcials buyer in Q3 2020 was BlackRock, an estimated $1.99M added.
  • The largest Eton Pharmaceutcials seller in Q3 2020 was Diametric Capital, an estimated $1.36M sold.

Based on aggregated 13F filings for Q3 2020.